Tanahashi, Toshiyuki
Yoshida, Kazuhiro
Yamaguchi, Kazuya
Okumura, Naoki
Takeno, Atsushi
Fujitani, Kazumasa
Fukushima, Norimasa
Takiguchi, Nobuhiro
Nishida, Yasunori
Boku, Narikazu
Yoshikawa, Takaki
Terashima, Masanori
Funding for this research was provided by:
Taiho Pharmaceutical
Ono Pharmaceutical
Chugai Pharmaceutical
Yakult Honsha
Eli Lilly Japan
Daiichi-Sankyo
Merck Serono
Novartis Pharma
EA Pharma
Johnson and Johnson
Covidien
Takeda Pharmaceutical Company
Nippon Kayaku
Sanofi
Otsuka Pharmaceutical
MSD
Bayer Yakuhin
Dainippon Sumitomo Pharma
Ministry of Health, Labor and Welfare
Ono Parmaceutical
Kaken Pharmaceutical
Olympus
Article History
Received: 11 January 2018
Accepted: 3 May 2018
First Online: 24 May 2018
<!--Emphasis Type='Bold' removed-->Compliance with ethical standards
:
: K. Yoshida has received grant, personal fees and nonfinancial support from Taiho Pharm. Co., Ltd; Ono Pharm. Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Yakult Honsha Co., Ltd.; Eli Lilly Japan K.K.; Daiichi Sankyo Co., Ltd.; Merk Serono Co., Ltd.; Novartis Pharma; EA Pharma Co., Ltd.; Takeda Pharmaceutical Company; Sanofi K.K.; grant and personal fees from Johnson & Johnson K.K.; Covidien Japan; grant from Nippon Kayaku Co., Ltd.; Otsuka Pharma Co., Ltd.; Dainippon Sumitomo Pharma; personal fees from MSD K.K.; Bayer Yakuhin, Ltd. N. Takiguchi has received grant from Ministry of Health, Labor and Welfare, Japan. N. Boku has received grant and personal fees from Taiho Pharm. Co., Ltd. T. Yoshikawa has received grant from Japanese Foundation for Multidisciplinary Treatment of Cancer; grant and personal fees from Chugai Pharmaceutical Co., Ltd.; Taiho Pharm. Co., Ltd; Noartis Pharma; personal fees from Abbott Japan; Ono Pharm. Co., Ltd.; Eli Lilly Japan K.K.; Kaken Pharmaceutical; Yakult Honsha Co., Ltd.; Nippon Kayaku Co., Ltd.; Johnson & Johnson K.K.; Covidien Japan; Takeda Pharmaceutical Company; Olympus. All remaining authors declared that they have no conflict of interest.
: All the questions asked in this survey were about the preference of the clinical practice of each investigator. Any patient information such as names, initials, addresses, admission dates, hospital numbers, or any other data that might identify patients were not asked or included in this survey.